Re: https://www.hifa.org/dgroups-rss/plos-global-public-health-tb-stigma-india
Stigma is actual not only for TB but for many infectious diseases, and it can influence a lot the disease spread. Stigmatization varies a lot for the same disease in different countries. For example, in our analysis related to Covid-19 https://doi.org/10.1371/journal.pone.0274902, we found the overt fear of stigmatization was expressed by almost 20% of those who would not share contacts (and probably this fear was masked by a part of respondents indicating they do not want to disturb contact persons), but they represented only a small part of all participants, while stigmatization fear could be expressed by 65-75% of individuals in countries of Africa [34] or Asia [36], by 57% in China [12] and by 46% (but only 7% expressed high stigma score) in the USA [37]. [*see note below]
HIFA profile: Boris Bikbov is a Senior Researcher at Scientific-Tools.Org, Italy. Professional interests: Public health; Non-comunicable diseases; Kidney disease, chronic and acute; Diabetes; Cardiovascular diseases; Data management; Statistical analysis.
boris.bikbov AT gmail.com
[*Note from HIFA moderator (NPW): Thank you Boris. All: The numbers 36,12,37 relate to references that can be consulted in the original paper. Boris Bikbov is the lead author.
CITATION: Willingness to share contacts in case of COVID-19 positivity – predictors of collaboration resistance in a nation-wide Italian survey
Boris Bikbov et al. PLOS One. Published: September 27, 2022
https://doi.org/10.1371/journal.pone.0274902
I shall ask ChatGPT to prepare a plain-language summary which I shall forward in a separate message. I would be interested to learn from Boris if there are any inaccuracies.]